RVKA Stock Overview
Develops, manufactures, and distributes medical diagnostics products for the food sensitivity testing market in the United Kingdom, rest of Europe, North America, South/Central America, India, rest of Asia and the Far East, Africa, and the Middle East.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Cambridge Nutritional Sciences plc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | UK£0.028 |
| 52 Week High | UK£0.05 |
| 52 Week Low | UK£0.025 |
| Beta | 3.89 |
| 11 Month Change | -8.20% |
| 3 Month Change | -3.45% |
| 1 Year Change | 12.00% |
| 33 Year Change | -94.31% |
| 5 Year Change | n/a |
| Change since IPO | -96.03% |
Recent News & Updates
Recent updates
Shareholder Returns
| RVKA | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | 1.8% | 8.9% | 1.1% |
| 1Y | 12.0% | 3.6% | 12.5% |
Return vs Industry: RVKA exceeded the German Medical Equipment industry which returned 0.4% over the past year.
Return vs Market: RVKA matched the German Market which returned 11.8% over the past year.
Price Volatility
| RVKA volatility | |
|---|---|
| RVKA Average Weekly Movement | 11.1% |
| Medical Equipment Industry Average Movement | 5.1% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in DE Market | 11.6% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: RVKA's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: RVKA's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | 94 | James Cooper | www.cnsplc.com |
Cambridge Nutritional Sciences plc, together with its subsidiaries, develops, manufactures, and distributes medical diagnostics products for the food sensitivity testing market in the United Kingdom, rest of Europe, North America, South/Central America, India, rest of Asia and the Far East, Africa, and the Middle East. The company is involved in the research, development, and production of kits for detection of immune reactions to food under the FoodPrint brand. It also provides clinical analysis to the general public, clinics, and health professionals; and supplies Food Detective, a food sensitivity test.
Cambridge Nutritional Sciences plc Fundamentals Summary
| RVKA fundamental statistics | |
|---|---|
| Market cap | €9.16m |
| Earnings (TTM) | -€394.39k |
| Revenue (TTM) | €11.75m |
0.8x
P/S Ratio-23.2x
P/E RatioIs RVKA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| RVKA income statement (TTM) | |
|---|---|
| Revenue | UK£9.77m |
| Cost of Revenue | UK£3.73m |
| Gross Profit | UK£6.05m |
| Other Expenses | UK£6.37m |
| Earnings | -UK£328.00k |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.0014 |
| Gross Margin | 61.86% |
| Net Profit Margin | -3.36% |
| Debt/Equity Ratio | 0% |
How did RVKA perform over the long term?
See historical performance and comparison